Immunome, Inc.

NASDAQ:IMNM

15.97 (USD) • At close September 13, 2024
Bedrijfsnaam Immunome, Inc.
Symbool IMNM
Munteenheid USD
Prijs 15.97
Beurswaarde 959,068,768
Dividendpercentage 0%
52-weken bereik 6.65 - 30.958
Industrie Biotechnology
Sector Healthcare
CEO Dr. Clay B. Siegall Ph.D.
Website https://immunome.com

An error occurred while fetching data.

Over Immunome, Inc.

Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2

Vergelijkbare Aandelen

X4 Pharmaceuticals, Inc. logo

X4 Pharmaceuticals, Inc.

XFOR

0.71 USD

Tonix Pharmaceuticals Holding Corp. logo

Tonix Pharmaceuticals Holding Corp.

TNXP

0.157 USD

Cabaletta Bio, Inc. logo

Cabaletta Bio, Inc.

CABA

4.11 USD

Nutriband Inc. logo

Nutriband Inc.

NTRB

4.47 USD

Check-Cap Ltd. logo

Check-Cap Ltd.

CHEK

1.79 USD

Delcath Systems, Inc. logo

Delcath Systems, Inc.

DCTH

9.54 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)